Epidural Analgesia on Electrophysiological Function
Prolonged Labor, Healthy, Pelvic Floor Disorders
About this trial
This is an interventional supportive care trial for Prolonged Labor focused on measuring combined spinal-epidural analgesia, pelvic floor muscle, postpartum electrophysiological function
Eligibility Criteria
Inclusion Criteria:
- Primiparous women gave birth by vaginal delivery between June 2013 and June 2014 in the Maternal and Child Health Hospital of Nanning
- They were 22-30 years old
- They were 155-165 cm tall
- They were assigned a score of I or II on the American Society of Anesthesiologists scale
- They gave birth by vaginal delivery to a live, single, mature fetus (≥ 38, ≤ 40 w) in the head position
- A neonatal weight of 2900-3500 g
Exclusion Criteria:
- History of chronic cough
- Chronic constipation or pelvic organ resection
- Family history of urinary incontinence
- Pelvic organ prolapsus
- Any systemic disease before delivery
- A history of surgery, trauma, tumors or deformity of lumbar vertebrae
Sites / Locations
- Maternal and Child Health Hospital of Nanning City
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
CSEA group
Control group
Women in the CSEA group received CSEA during labor. An intravenous line was established when the uterine opening measured 1-2 cm. Then sufentanil (5-7 μg) was injected intrathecally. When the visual analogue pain score was 3 or higher, a mixture of ropivocaine (0.143%) and sufentanil (0.3 μg/ml) was continuously infused into the epidural space using an analgesia pump until the cervix was fully dilated. Load capacity was 5 ml. The analgesic plane was controlled under T10.
Women in the control group were not provided any analgesia during labor.